Surveys

On this page you will find a list of surveys from, or endorsed by, ABS members.

Submit a Survey

 

If you would like to submit a survey to gain input from the ABS membership please email a link or a list of questions to Ceris Harrison at cerisharrison@absgbi.org.uk

All surveys must be from, or endorsed by, an ABS or Mammary Fold member. Approved surveys will also be circulated in the ABS newsletter or monthly bulletin emails.


Breast reconstruction is now considered to be one of the pillars of breast cancer treatment. Before the introduction of acellular dermal matrix (ADM) there were limitations to the use of implant based reconstruction to which the ADM provides a solution. The use of ADM has increased the number of a single-stage direct to implant breast reconstructions subsequently reducing the number of two-stage reconstructions. Unfortunately however, there are several complications associated with the use of ADM of which seroma is the most frequent. The term seroma is not well defined in the international literature and it is still debatable if it is related to the use of an ADM, at what point we label it as a seroma and how best to manage it. The aim of this short survey is to help find the answers to those questions in order to better define the concept of seroma related to ADM.

G. Zoccali, N. Seyidova, R. Price, M. Ho-Asjoe.

Plastic Surgery department, Guy’s and St Thomas’ NHS Foundation Trust, London UK 

Click here to complete the survey and contact giovannizoccali81@gmail.com or 07490216119 with any questions.

ALCL - current Ireland/UK perspective

The purpose of this survey is to determine the current perspective of breast surgeons with regards to ALCL risk and breast implant practice.

 

Researchers are looking for healthcare professionals involved in the care of patients considering Contralateral Prophylactic Mastectomy (CPM) to take part in a study exploring the decision making process.

This will involve a 10-minute online survey, including questions about the decision making process, treatment pathways and your attitude towards CPM.

To take part, please visit:

https://tinyurl.com/UWE-CPM-Survey


If you’d be like to find out more about this research,
please contact Dr Pippa Tollow at the University of the West of England:

Pippa.Tollow@uwe.ac.uk
0117 32 87389

ATNEC: Axillary management in T1-3N1M0 breast cancer patients with FNA or core biopsy proven nodal metastases at presentation who convert to node negative after NEoadjuvant Chemotherapy

We would like to establish the level of interest in this proposed non-commercial study. Please find attached a trial summary for your information. The proposal is being submitted to NIHR HTA for funding. 

In order to register your interest in this study, we would be very grateful if you could review the trial summary and then complete the online survey at: https://crnem.typeform.com/to/SP3dNG no later than 15th December 2017

Important note: To aid completion of the survey and prior to entering your answers online, each of the questions may be reviewed in the attached PDF.  Please do not complete the PDF version.  All answers should be entered directly into the online survey. 

If you have any questions please contact Amit Goyal on amit.goyal@nhs.net or 01332 785538.

Find more information here and complete the survey here